A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927

Journal of Bacteriology

Volumn 182, Issue 12, 2000, Pages 3394-3399

  Behr, Marcel A ^a,c   Schroeder, Benjamin G ^b   Brinkman, Jacquelyn N ^a   Slayden, Richard A ^b   Barry III, Clifton E ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOLIC ACID;

ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; GENES, BACTERIAL; METHYLTRANSFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MYCOBACTERIUM BOVIS; MYCOLIC ACIDS; POINT MUTATION; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0034040723     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.182.12.3394-3399.2000     Document Type: Article

References (28)

1. Armbruster, C., W. Junker, N. Vetter, and G. Jaksch. 1990. Disseminated bacille Calmette-Guérin infection in an AIDS patient 30 years after BCG vaccination. J. Infect. Dis. 162:1216.
2. Barry, C. E., III, R. E. Lee, K. Mdluli, A. E. Sampson, B. G. Schroeder, R. A. Slayden, and Y. Yuan. 1998. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 37:143-179.
3. Behr, M. A., and P. M. Small. 1997. Has BCG attenuated to impotence? Nature 389:133-134.
4. Behr, M. A., and P. M. Small. 1999. A historical and molecular phylogeny of BCG strains. Vaccine 17:915-922.
5. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520-1523.
6. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544. (Erratum, 396:190.)
7. Dubnau, E., H. Marrakchi, I. Smith, M. Daffe, and A. Quemard. 1998. Mutations in the cmaB gene are responsible for the absence of methoxymycolic acid in Mycobacterium bovis BCG Pasteur. Mol. Microbiol. 29:1526-1528.
8. Dubos, R. J., C. H. Pierce, and W. B. Schaefer. 1953. Anti-tuberculosis immunity induced in mice by vaccination with living cultures of attenuated tubercle bacilli. J. Exp. Med. 97:207-220.
9. Fine, P. E. 1995. Bacille Calmette-Guérin vaccines: a rough guide. Clin. Infect. Dis. 20:11-14.
10. Frothingham, R., and W. A. Meeker-O'Connell. 1998. Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology. 144:1189-1196.
11. George, K. M., Y. Yuan, D. R. Sherman, and C. E. Barry III. 1995. The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis: identification and functional analysis of CMAS-2. J. Biol. Chem. 270:27292-27298.
12. Howard, S. T., A. Laszlo, and W. M. Johnson. 1997. Genetic identification of Mycobacterium bovis BCG by restriction fragment length polymorphism analysis of the direct-repeat region. J. Clin. Microbiol. 35:965-968.
13. Ingrosso, D., A. V. Fowler, J. Bleibaum, and S. Clarke. 1989. Sequence of the D-aspartyl/L-isoaspartyl protein methyltransferase from human erythrocytes. Common sequence motifs for protein, DNA, RNA, and small molecule 5-adenosylmethionine-dependent methyltransferases. J. Biol. Chem. 264: 20131-20139.
14. Jensen, K. A. 1946. Practice of the Calmette vaccination. Acta Tuberc. Scand. 20:1-45.
15. Kroger, L., E. Brander, M. Korppi, O. Wasz-Hockert, A. Backman, H. Kroger, K. Launiala, and M. L. Katila. 1994. Osteitis after newborn vaccination with three different Bacillus Calmette-Guérin vaccines: twenty-nine years of experience. Pediatr. Infect. Dis. J. 13:113-116.
16. Magdalena, J., P. Supply, and C. Locht. 1998. Specific differentiation between Mycobacterium bovis BCG and virulent strains of the Mycobacterium tuberculosis complex. J. Clin. Microbiol. 36:2471-2476.
17. Mahairas, G. G., P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover. 1996. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178:1274-1282.
18. Minnikin, D. E., S. M. Minnikin, G. Dobson, M. Goodfellow, F. Portaels, L. van den Breen, and D. Sesardic. 1983. Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J. Gen. Microbiol. 129:889-891.
19. Oettinger, T., M. Jorgensen, A. Ladefoged, K. Haslov, and P. Andersen. 1999. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber. Lung Dis. 79:243-250.
20. Osborn, T. W. 1983. Changes in BCG strains. Tubercle 64:1-13.
21. Petroff, S. A. 1929. A new analysis of the value and safety of protective immunization with BCG. Am. Rev. Tuberc. 20:275-296.
22. Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs, Jr. 1990. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911-1919.
23. ten Dam, H. G. 1993. BCG vaccination, p. 251-274. In L. B. Reichman and E. S. Hershfield (ed.), Tuberculosis: a comprehensive international approach. Marcel Dekker, New York, N.Y.
24. van Soolingen, D., P. W. Hermans, P. E. de Haas, D. R. Soll, and J. D. van Embden. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
25. Vitkova, E., J. Galliova, K. Krepela, and M. Kubin. 1995. Adverse reactions to BCG. Cent. Eur. J. Public Health 3:138-141.
26. Yuan, Y., and C. E. Barry III. 1996. A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 93:12828-12833.
27. Yuan, Y., Y. Zhu, D. D. Crane, and C. E. Barry III. 1998. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol. Microbiol. 29:1449-1458.
28. Zeyland, J., and E. Piasecka-Zeyland. 1936. Sur la vitalité du BCG dans l'organisme vacciné. Ann. Inst. Pasteur 56:46-51.